Surveillance of Enterobacteriaceae from Diabetic Foot Infections in a Tunisian Hospital: Detection of E. coli-ST131-blaCTX-M-15 and K. pneumoniae-ST1-blaNDM-1 Strains
- Arfaoui, Ameni 3
- Martínez-Álvarez, Sandra 1
- Abdullahi, Idris Nasir 1
- Fethi, Meha 3
- Sayem, Noureddine 2
- Melki, Salma Ben Khelifa 2
- Ouzari, Hadda-Imene 3
- Torres, Carmen 1
- Klibi, Naouel 3
-
1
Universidad de La Rioja
info
- 2 Service of Biology, International Hospital Center Carthagene of Tunisia, Tunis, Tunisia.
-
3
Université de Tunis El Manar
info
ISSN: 1076-6294, 1931-8448
Any de publicació: 2024
Tipus: Article
beta Ver similares en nube de resultadosAltres publicacions en: Microbial Drug Resistance
Resum
The study determined the prevalence, antimicrobial resistant (AMR) determinants, and genetic characteristics of Escherichia coli and Klebsiella pneumoniae isolates from patients with diabetic foot infection (DFI) in a Tunisian hospital. A total of 26 Escherichia spp. and Klebsiella spp. isolates were recovered and identified by MALDI-TOF-MS. Antimicrobial susceptibility testing, the detection of AMR determinants and Shiga-like toxin genes, phylogenetic grouping, and molecular typing were performed. Twelve E. coli, 10 K. pneumoniae, 3 K. oxytoca, and 1 E. hermanii were isolated. A multidrug-resistant phenotype was detected in 65.4% of the isolates. About 30.8% of isolates were extended-spectrum β-lactamase (ESBL) producers and mainly carried blaCTX-M-15 and blaCTX-M-14 genes. One blaNDM-1-producing K. pneumoniae-ST1 strain was identified. Class 1 integrons were detected in 11 isolates and 5 gene cassette arrangements were noted: dfrA1+aadA1 (n = 1), dfrA12+aadA2 (n = 3), and dfrA17+aadA5 (n = 1). Other non-β-lactam resistance genes detected were as follows (number of isolates): aac(3')-II (3), aac(6')–Ib-cr(8), qnrB (2), qnrS (4), cmlA (2), floR (4), sul1 (11), sul2 (11), and sul3 (2). The phylogroup B1 was the most frequent (41.7%) among E. coli, and two ESBL-producing isolates corresponded to the ST131-B2 lineage. The ESBL- and carbapenemase-producing Enterobacteriaceae in DFIs are described for the first time in Tunisia.
Referències bibliogràfiques
- 10.1038/nrendo.2016.53
- 10.1016/j.jcot.2021.01.017
- 10.1016/j.jvs.2019.08.229
- 10.1089/wound.2021.0118
- 10.1053/j.semvascsurg.2019.02.001
- 10.1093/cid/ciad255
- 10.3390/ijms24043913
- 10.4239/wjd.v14.i6.680
- 10.21315/mjms2019.26.1.10
- 10.1016/j.jiac.2015.12.007
- 10.1080/14787210.2020.1767593
- 10.1007/s40265-019-01180-3
- 10.18231/j.ijmr.2019.033
- 10.1155/2021/5153237
- Liu B, (2019), Journal of Henan Agricultural Sciences, 48, pp. 1
- 10.1093/jacamr/dlab092
- 10.3389/fmicb.2012.00110
- 10.1128/JCM.01076-06
- 10.1179/joc.2010.22.5.318
- 10.1007/s00284-011-9930-4
- 10.1017/S0950268817002266
- 10.1186/s12864-018-4976-3
- 10.1086/653932
- 10.1093/jac/dkq415
- 10.1128/CMR.00125-13
- 10.3390/ijms21145090
- 10.1097/QCO.0000000000000530
- 10.1016/j.micres.2022.127249
- 29. CLSI. Performance Standards for Antimicrobial Susceptibility Testing Twenty-Third Informational Supplement; CLSI Document; CLSI: Orlando, FL, USA; 2020; p. M100-S23.
- 10.1111/j.1469-0691.2011.03570.x
- 10.3390/antibiotics11040444
- 10.1128/AAC.48.10.3996-4001.2004
- 10.1371/journal.pone.0250525
- 10.1016/j.vetmic.2010.01.026
- 10.1111/1758-2229.12019
- 10.1128/JCM.02562-14
- 10.1128/JCM.00860-12
- 10.3855/jidc.16660
- 10.1089/dia.2011.0197
- 10.3823/269
- 10.4314/ahs.v19i3.26
- Ben Moussa M, (2016), Tunis Med, 94, pp. 95
- 10.1016/j.ando.2015.07.852
- 10.22467/jwmr.2017.00108
- 10.4103/2141-9248.141541
- 10.4103/IJAM.IJAM_57_20
- 10.1177/15347346211038090
- 10.1016/S0255-0857(21)02830-9
- Ananthakrishnan AN, (2004), Indian J Med Microbiol, 18, pp. 160
- 10.2337/dc06-0116
- 10.4103/0377-4929.42513
- 10.2147/IDR.S371431
- 10.1590/s1413-86702003000200006
- 10.1016/S0255-0857(21)02352-5
- 10.1016/j.ijid.2018.02.013
- 10.1016/j.dsx.2020.02.010
- 10.1371/journal.pone.0068234
- 10.3892/etm.2016.2996
- 10.1128/mBio.00470-18
- 10.1089/mdr.2019.0076
- 10.3389/fmicb.2016.01859
- 10.1007/s12223-013-0292-0
- 10.1093/jac/dkp194
- 10.1016/j.tvjl.2014.12.026
- 10.3389/fmicb.2019.01753
- 10.3390/antibiotics11101329
- 10.1371/journal.pone.0105016
- 10.3390/pathogens9050357
- 10.1099/jmm.0.045229-0
- 10.1089/mdr.2018.0013
- 10.2147/IDR.S259562
- 10.1099/jmm.0.039008-0
- 10.1080/23744235.2017.1407038
- 10.1016/j.bjm.2017.09.003
- 10.1111/j.1348-0421.2009.00168.x
- 10.3389/fmicb.2015.00601
- 10.3390/pathogens11080948